OptimizeRx Corporation (OPRX)

Market Cap	161.42M
Revenue (ttm)	92.13M
Net Income (ttm)	-20.11M
Shares Out	18.49M
EPS (ttm)	-1.10
PE Ratio	n/a
Forward PE	22.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	227,150
Open	8.75
Previous Close	8.74
Day's Range	8.70 - 9.30
52-Week Range	3.78 - 14.13
Beta	1.31
Analysts	Buy
Price Target	9.06 (+3.78%)
Earnings Date	Mar 12, 2025

About OPRX

OptimizeRx Corporation, a digital health technology company, engages in the provision of tech-enabled marketing solutions for life sciences organizations, healthcare providers, and patients. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2006
• Employees: 129
• Stock Exchange: NASDAQ
• Ticker Symbol: OPRX
• Website: https://www.optimizerx.com

Financial Performance

In 2024, OptimizeRx's revenue was $92.13 million, an increase of 28.81% compared to the previous year's $71.52 million. Losses were -$20.11 million, 14.5% more than in 2023.

Analyst Forecast

According to 8 analysts, the average rating for OPRX stock is "Buy." The 12-month stock price forecast is $9.06, which is an increase of 3.78% from the latest price.

Price Target

$9.06

(3.78% upside)

Analyst Consensus: Buy